Building inner ears: recent advances and future challenges for in vitro organoid systems

WH van der Valk, MR Steinhart, J Zhang… - Cell Death & …, 2021 - nature.com
While inner ear disorders are common, our ability to intervene and recover their sensory
function is limited. In vitro models of the inner ear, like the organoid system, could aid in …

[HTML][HTML] Non-syndromic hearing loss gene identification: A brief history and glimpse into the future

B Vona, I Nanda, MAH Hofrichter… - Molecular and cellular …, 2015 - Elsevier
From the first identified non-syndromic hearing loss gene in 1995, to those discovered in
present day, the field of human genetics has witnessed an unparalleled revolution that …

Cochlear afferent innervation development

L Delacroix, B Malgrange - Hearing Research, 2015 - Elsevier
Sound signal is detected by sensory hair cells located in the cochlear region of the inner ear,
and transmitted to the central nervous system by the spiral ganglion neurons (SGNs). These …

A New Pathogenic Variant in POU3F4 Causing Deafness Due to an Incomplete Partition of the Cochlea Paved the Way for Innovative Surgery

AM Tekin, M Matulic, W Wuyts, MZ Assadi, G Mertens… - Genes, 2021 - mdpi.com
Incomplete partition type III (IP-III) is a relatively rare inner ear malformation that has been
associated with a POU3F4 gene mutation. The IP-III anomaly is mainly characterized by …

Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing

Z Brownstein, A Abu-Rayyan… - European Journal of …, 2014 - nature.com
Hereditary hearing loss is genetically heterogeneous, with a large number of genes and
mutations contributing to this sensory, often monogenic, disease. This number, as well as …

Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss

A Pollak, U Lechowicz, A Kędra, P Stawiński… - PloS one, 2016 - journals.plos.org
POU3F4 mutations (DFNX2) are the most prevalent among non-syndromic X-linked hearing
loss (HL) identified to date. Clinical manifestations of DFNX2 usually comprise congenital …

Clinical and molecular aspects associated with defects in the transcription factor POU3F4: A review

E Bernardinelli, F Huber, S Roesch, S Dossena - Biomedicines, 2023 - mdpi.com
X-linked deafness (DFNX) is estimated to account for up to 2% of cases of hereditary
hearing loss and occurs in both syndromic and non-syndromic forms. POU3F4 is the gene …

Frequency and specific characteristics of the incomplete partition type III anomaly in children

A Kanno, H Mutai, K Namba, N Morita… - The …, 2017 - Wiley Online Library
Objectives/Hypothesis To determine the frequency of the incomplete partition type III
anomaly and the genetic and clinical features associated with POU3F4 mutations in children …

Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation

E Bernardinelli, S Roesch, E Simoni… - Frontiers in Molecular …, 2022 - frontiersin.org
Hearing loss (HL) is the most common sensory defect and affects 450 million people
worldwide in a disabling form. Pathogenic sequence alterations in the POU3F4 gene, which …

[HTML][HTML] Spatially distinct otic mesenchyme cells show molecular and functional heterogeneity patterns before hearing onset

KP Rose, G Manilla, B Milon, O Zalzman, Y Song… - Iscience, 2023 - cell.com
The cochlea consists of diverse cellular populations working in harmony to convert
mechanical stimuli into electrical signals for the perception of sound. Otic mesenchyme cells …